Skip to main content
SpringerLink
Log in

Management of Patients with Dementia: An Introduction

  • Chapter
  • First Online:
Management of Patients with Dementia

Abstract

Dementia is a syndrome of cognitive impairment leading to reduced ability to carry out activities of daily living. The most common neurodegenerative dementia diseases are Alzheimer’s disease, frontotemporal dementia, and Lewy body dementia. Vascular dementia is also a common cause of dementia. The disease course is variable but is usually with an insidious onset and slowly progressive. Care for patients with dementia and the medical management of dementia disorders require a multi-professional approach which will often include a physician. Moreover, physicians outside those specialties usually involved in the diagnosis and medical management of patients with dementia are likely to treat patients with dementia, and they need to be knowledgeable about dementia. Apart from cognitive impairment, patients with dementia may have reduced insight, behavioral disturbances, a lower threshold for developing delirium and adverse reactions to pharmacological treatment, difficulties in communicating, and other issues which the physician needs to take into consideration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AD:

Alzheimer’s disease

FTD:

Frontotemporal dementia

LBD:

Lewy body dementia

VaD:

Vascular dementia

ADL:

Activities of daily living

MCI:

Mild cognitive impairment

References

  1. International classification of diseases for mortality and morbidity statistics (11th Revision). World Health Organization; 2018.

    Google Scholar 

  2. Diagnostic and statistical manual of mental disorders. 5th edition. Washington, DC: American Psychiatric Association; 2013.

    Google Scholar 

  3. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303–8.

    Article  CAS  PubMed  Google Scholar 

  4. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256(3):240–6.

    Article  CAS  PubMed  Google Scholar 

  5. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):280–92.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–9.

    Article  PubMed  PubMed Central  Google Scholar 

  7. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging and the Alzheimer’s Association workgroup. Alzheimers Dement. 2011;7(3):263–9.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614–29.

    Article  PubMed  Google Scholar 

  9. Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimer’s Dement. 2018;14(4):535–62.

    Article  Google Scholar 

  10. Mckeith IG, Sci M, Boeve BF, Dickson DW, Halliday G, Taylor J-P, et al. Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88–100.

    Article  PubMed  PubMed Central  Google Scholar 

  11. McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020;94(17):743–55. https://doi.org/10.1212/WNL.0000000000009323.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Sachdev P, Kalaria R, O’Brien J, Skoog I, Alladi S, Black SE, et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;13:1–13.

    Google Scholar 

  13. Gorno-Tempini M, Hillis A, Weintraub S. Classification of primary progressive aphasia and its variants. Neurology;2011.

    Google Scholar 

  14. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(9):2456–77.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142(6):1503–27.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Prince M, Wimo A, Guerchet M, Ali G, Wu Y, Prina M. The global impact of dementia: an analysis of prevalence, incidence, cost and trends. London: Alzheimer’s Disease International. World Alzheimer Report 2015; 2015.

    Google Scholar 

  17. Dementia - a public health priority. WHO and Alzheimer’s Disease International 2012 (www.who.int/mental_health/publications/dementia_report_2012/en).

  18. Prince M, Ali G-C, Guerchet M, Prina AM, Albanese E, Wu Y-T. Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimers Res Ther. 2016;8(1):23.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A. 2011;108(7):3017–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Stephan BCM, Birdi R, Tang EYH, Cosco TD, Donini LM, Licher S, et al. Secular trends in dementia prevalence and incidence worldwide: a systematic review. J Alzheimers Dis. 2018;66(2):653–80.

    Article  PubMed  Google Scholar 

  21. Taudorf L, Nørgaard A, Islamoska S, Jørgensen K, Laursen TM, Waldemar G. Declining incidence of dementia: a national registry-based study over 20 years. Alzheimers Dement. 2019;15(11):1383–91.

    Article  PubMed  Google Scholar 

  22. Taudorf L, Nørgaard A, Waldemar G, Laursen TM. Mortality in dementia from 1996 to 2015: a national registry-based cohort study. J Alzheimers Dis. 2021;79(1):289–300.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12(2):207–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med. 2012;367(9):795–804.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Jessen F, Amariglio RE, Van Boxtel M, Breteler M, Ceccaldi M, Chételat G, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimers Dement. 2014;10(6):844–52.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Slot RER, SAM S, Berkhof J, Brodaty H, Buckley R, Cavedo E, et al. Subjective cognitive decline and rates of incident Alzheimer’s disease and non–Alzheimer’s disease dementia. Alzheimer’s Dement. 2018;15:465–76.

    Article  Google Scholar 

  27. Hu C, Yu D, Sun X, Zhang M, Wang L, Qin H. The prevalence and progression of mild cognitive impairment among clinic and community populations: A systematic review and meta-analysis. Int Psychogeriatrics. 2017;29(10):1595–608.

    Article  Google Scholar 

  28. Savva GM, Zaccai J, Matthews FE, Davidson JE, Mckeith I, Brayne C. Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. Br J Psychiatry. 2009;194:212–9.

    Article  PubMed  Google Scholar 

  29. Sadak TI, Katon J, Beck C, Cochrane BB, Borson S. Key neuropsychiatric symptoms in common dementias: prevalence and implications for caregivers, clinicians, and health systems. Res Gerontol Nurs. 2015;7(1):44–52.

    Article  Google Scholar 

  30. Pereira GCM, De Oliveira GC. Prevalence of capgras syndrome in Alzheimer’s patients: a systematic review and meta-analysis. Dement e Neuropsychol. 2019;13(4):463–8.

    Article  Google Scholar 

  31. Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med. 2016;8(6):595–608.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Aisen PS. Editorial: failure after failure. What next in AD drug development? J Prev Alzheimer’s Dis. 2019;6(3):150.

    CAS  Google Scholar 

  33. Heneka MT, Golenbock DT, Latz E. Innate immunity in Alzheimer’s disease. Nat Immunol. 2015;16(3):229–36.

    Article  CAS  PubMed  Google Scholar 

  34. Cole J, Costafreda SG, McGuffin P, Fu CHY. Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies. J Affect Disord. 2011;134(1–3):483–7.

    Article  PubMed  Google Scholar 

  35. Woodward M, Jacova C, Black SE, Kertesz A, Mackenzie IR, Feldman H. Differentiating the frontal variant of Alzheimer’s disease. Int J Geriatr Psychiatry. 2009;25(7):732–8.

    Article  Google Scholar 

  36. Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC. Posterior cortical atrophy. Lancet Neurol. 2012;11:170–8.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Henry ML, Gorno-Tempini ML. The logopenic variant of primary progressive aphasia. Curr Opin Neurol. 2010 Dec;23(6):633–7.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Marques IB, Tabuas-Pereira M, Milheiro M, Santana I. Biparietal variant of Alzheimer’s disease: a rare presentation of a common disease. Case Reports. 2015;2015:bcr2014207011.

    Google Scholar 

  39. Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD. The diagnosis of young-onset dementia. Lancet Neurol. 2010;9(8):793–806.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Bekris LM, Yu C-E, Bird TD, Tsuang DW. Review article: genetics of Alzheimer disease. J Geriatr Psychiatry Neurol. 2010;23(4):213–27.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Piguet O, Hornberger M, Mioshi E, Hodges JR. Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management. Lancet Neurol. 2011;10(2):162–72.

    Article  PubMed  Google Scholar 

  42. Desgranges B, Matuszewski V, Piolino P, Chételat G, Mézenge F, Landeau B, et al. Anatomical and functional alterations in semantic dementia: a voxel-based MRI and PET study. Neurobiol Aging. 2007;28(12):1904–13.

    Article  PubMed  Google Scholar 

  43. Greaves CV, Rohrer JD. An update on genetic frontotemporal dementia. J Neurol. 2019;266(8):2075–86.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Rohrer JD, Isaacs AM, Mizielinska S, Mead S, Lashley T, Wray S, et al. C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. Lancet Neurol. 2015;14:291–301.

    Article  CAS  PubMed  Google Scholar 

  45. Janvin CC, Larsen JP, Aarsland D, Hugdahl K. Subtypes of mild cognitive impairment in parkinson’s disease: progression to dementia. Mov Disord. 2006;21(9):1343–9.

    Article  PubMed  Google Scholar 

  46. Johnson DK, Morris JC, Galvin JE. Verbal and visuospatial deficits in dementia with Lewy bodies. Neurol Int. 2005;65(8):1232–8.

    Article  Google Scholar 

  47. Gjerum L, Frederiksen KS, Henriksen OM, Law I, Anderberg L, Andersen BB, et al. A visual rating scale for cingulate island sign on 18F-FDG-PET to differentiate dementia with Lewy bodies and Alzheimer’s disease. J Neurol Sci. 2020;410:116645.

    Article  CAS  PubMed  Google Scholar 

  48. Graff-Radford J, Murray ME, Lowe VJ, Boeve BF, Ferman TJ, Przybelski SA, et al. Dementia with Lewy bodies: basis of cingulate island sign. Neurology. 2014;83(9):801–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Calderon J. Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2001;70(2):157–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Maetzler W, Liepelt I, Reimold M, Reischl G, Solbach C, Becker C, et al. Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics. Neurobiol Dis. 2009;34(1):107–12.

    Article  CAS  PubMed  Google Scholar 

  51. De Reuck JL, Deramecourt V, Auger F, Durieux N, Florence CM, Charlotte P, et al. Cerebrovascular lesions in mixed neurodegenerative dementia: a neuropathological and magnetic resonance study. Eur Neurol. 2017;78(1–2):1–4.

    Article  PubMed  Google Scholar 

  52. Román GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1(7):426–36.

    Article  PubMed  Google Scholar 

  53. van der Flier WM, van Straaten ECW, Barkhof F, Verdelho A, Madureira S, Pantoni L, et al. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke. 2005;36(10):2116–20.

    Article  PubMed  Google Scholar 

  54. De Reuck J. Frequency and topography of small cerebrovascular lesions in vascular and in mixed dementia: a post-mortem 7-tesla magnetic resonance imaging study with neuropathological correlates. Folia Neuropatol. 2017;55:31–7.

    Article  Google Scholar 

  55. Erkinjuntti T. Subcortical vascular dementia. Cerebrovasc Dis Dis. 2000;13(2):58–60.

    Google Scholar 

  56. Jellinger KA. Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci. 2013;5:17.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  57. Zerr I, Parchi P. Sporadic Creutzfeldt–Jakob disease. Handb Clin Neurol. 2018;153:155–74.

    Article  PubMed  Google Scholar 

  58. Lesman-Segev OH, La Joie R, Stephens ML, Sonni I, Tsai R, Bourakova V, et al. Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy. NeuroImage Clin. 2019;24:102025.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Danish Dementia Research Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

    Kristian Steen Frederiksen & Gunhild Waldemar

Authors
  1. Kristian Steen Frederiksen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gunhild Waldemar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kristian Steen Frederiksen .

Editor information

Editors and Affiliations

  1. Danish Dementia Research Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

    Kristian Steen Frederiksen

  2. Danish Dementia Research Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

    Gunhild Waldemar

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Frederiksen, K.S., Waldemar, G. (2021). Management of Patients with Dementia: An Introduction. In: Frederiksen, K.S., Waldemar, G. (eds) Management of Patients with Dementia. Springer, Cham. https://doi.org/10.1007/978-3-030-77904-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-77904-7_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-77903-0

  • Online ISBN: 978-3-030-77904-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation